Select a product:
Infectious disease
Bone and mineral metabolism
Endocrinology
Oncology
Liaison ®
Spq protein
Autoimmunity
Therapeutic drug monitoring
Cns
International Catalog
ONCOLOGY
LIAISON® Calcitonin II Gen Specimen Diluent |
310652 |
Intended use |
For diluting specimens with levels of Calcitonin > 2000 pg/mL |
LIAISON® Calcitonin II Gen |
310650 |
Intended use |
For the quantitative determination of calcitonin in human serum |
Material provided |
Reagent Integral for 100 determinations |
Method |
Direct, two-site, sandwich type immunolumiometric assay using directly coated magnetic microparticle |
Detection limit |
1 pg/mL |
Calibrators |
Included |
Incubations |
30 min |
Measuring range |
1.0-2000 pg/mL |
Sample type |
Serum |
Sample size |
200 µL |
LIAISON® Thymidine Kinase |
310960 |
Intended use |
For the quantitative determination of the Thymidine Kinase enzymatic activity |
Label |
LIAISON® Thymidine Kinase |
Material provided |
Reagent for 100 determinations |
Method |
Indirect, modified 2-step, competitive chemiluminescent immunoassay |
Calibrators |
Included |
Incubations |
60 min |
Sample type |
Serum, and EDTA Plasma |
LIAISON® Thymidine Kinase Specimen Diluent Set |
310962 |
Intended use |
For diluting specimens with high levels of Thymidine Kinase > 100 U/L. |
LIAISON® CEA |
314311 |
Intended use |
For the quantitative determination of Carcinoembryonic Antigen (CEA). |
Material provided |
Reagent Integral for 100 determinations. |
Method |
2-step immunoluminometric sandwich assay using directly coated magnetic microparticles |
Detection limit |
0.2 ng/mL (MRC 73/601) |
Calibrators |
and Diluent included |
Incubations |
20 min (10 min + 10 min) |
Measuring range |
0.2-1000 ng/mL |
Sample type |
Serum/Plasma |
Sample size |
50 µL |
LIAISON® AFP |
314471 |
Intended use |
For the quantitative determination of Alpha-Fetoprotein (AFP). |
Material provided |
Reagent Integral for 100 determinations. |
Method |
2-step immunoluminometric sandwich assay using directly coated magnetic microparticles |
Detection limit |
0.2 IU/mL (MRC 72/225) |
Calibrators |
and Diluent included |
Incubations |
20 min (10 min + 10 min) |
Measuring range |
0.2-1000 IU/mL |
Sample type |
Serum/Plasma/Amniotic Fluid |
Sample size |
25 µL |
LIAISON® CA 19-9™ |
314171 |
Intended use |
For the quantitative determination of 1116-NS-19-9 Defined Antigen (CA 19-9). |
Material provided |
Reagent Integral for 100 determinations. |
Method |
2-step immunoluminometric sandwich assay using directly coated magnetic microparticles |
Detection limit |
0.3 U/mL. |
Calibrators |
and Diluent included |
Incubations |
20 min (10 min + 10 min) |
Measuring range |
0.3-1000 U/mL |
Sample type |
Serum/Plasma |
Sample size |
100 µL |
LIAISON® CA 125 II™ |
314211 |
Intended use |
For the quantitative determination of OC125 Defined Antigen (CA 125). |
Material provided |
Reagent Integral for 100 determinations. |
Method |
2-step immunoluminometric sandwich assay using directly coated magnetic microparticles |
Detection limit |
0.2 U/mL. |
Calibrators |
and Diluent included |
Incubations |
20 min (10 min + 10 min) |
Measuring range |
0.2-1000 U/mL |
Sample type |
Serum/Plasma |
Sample size |
100 µL |
LIAISON® CA 15-3® |
314301 |
Intended use |
For the quantitative determination of DF3 Defined Antigen (CA 15-3). |
Material provided |
Reagent Integral for 100 determinations. |
Method |
2-step immunoluminometric sandwich assay using directly coated magnetic microparticles |
Detection limit |
0.3 U/mL. |
Calibrators |
and Diluent included |
Incubations |
20 min (10 min + 10 min) |
Measuring range |
0.3-1000 U/mL |
Sample type |
Serum/Plasma |
Sample size |
10 µL |
LIAISON® PSA |
314381 |
Intended use |
For the quantitative determination of Total Prostate-Specific Antigen (T-PSA). |
Material provided |
Reagent Integral for 100 determinations. |
Method |
2-step immunoluminometric sandwich assay using directly coated magnetic microparticles |
Detection limit |
0.09 ng/mL (NIBSC 96/670) |
Calibrators |
and Diluent included |
Incubations |
20 min (10 min + 10 min) |
Measuring range |
0.09-300 ng/mL |
Sample type |
Serum/Plasma |
Sample size |
50 µL |
LIAISON® fPSA |
314391 |
Intended use |
For the quantitative determination of free Prostate-Specific Antigen (f-PSA). |
Material provided |
Reagent Integral for 100 determinations. |
Method |
1-step immunoluminometric sandwich assay using directly coated magnetic microparticles |
Detection limit |
0.04 ng/mL. |
Calibrators |
and Diluent included |
Incubations |
10 min |
Measuring range |
0.04-25 ng/mL |
Sample type |
Serum/Plasma |
Sample size |
50 µL |
Comments |
Not available in all countreis |
LIAISON® Ferritin |
313551 |
Intended use |
For the quantitative determination of Ferritin. |
Material provided |
Reagent Integral for 100 determinations. |
Method |
1-step immunoluminometric sandwich assay using directly coated magnetic microparticles |
Detection limit |
0.5 ng/mL (NIBSC 80/578) |
Calibrators |
Included |
Incubations |
10 min |
Measuring range |
0.5-3000 ng/mL |
Sample type |
Serum/Plasma |
Sample size |
10 µL |
LIAISON® TPA® -M |
314121 |
Intended use |
For the quantitative determination of Tissue Polypeptide Antigen (TPA). |
Material provided |
Reagent Integral for 100 determinations. |
Method |
2-step immunoluminometric sandwich assay using directly coated magnetic microparticles |
Detection limit |
2.0 U/L. |
Calibrators |
and Diluent included |
Incubations |
20 min (10 min + 10 min) |
Measuring range |
2-4000 U/L |
Sample type |
Serum |
Sample size |
100 µL |
LIAISON® NSE |
314561 |
Intended use |
For the quantitative determination of Neuron-Specific Enolase (NSE). |
Material provided |
Reagent Integral for 100 determinations. |
Method |
1-step immunoluminometric sandwich assay using directly coated magnetic microparticles |
Detection limit |
0.04 µg/L. |
Calibrators |
and Diluent included |
Incubations |
10 min |
Measuring range |
0.04-200 µg/L |
Sample type |
Serum |
Sample size |
25 µL |
LIAISON® S100 |
314701 |
Intended use |
For the quantitative determination of Protein S-100 B. |
Material provided |
Reagent Integral for 100 determinations.Diluent included |
Method |
2-step immunoluminometric sandwich assay using directly coated magnetic microparticles |
Detection limit |
0.02 µg/L. |
Calibrators |
extra |
Incubations |
20 min (10 min + 10 min) |
Measuring range |
0.02-30 µg/L |
Sample type |
Serum/CSF |
Sample size |
100 µL |
LIAISON® β2-Microglobulin |
314501 |
Intended use |
For the quantitative determination of β2-Microglobulin |
Material provided |
Reagent Integral for 100 determinations. |
Method |
1-step immunoluminometric sandwich assay using directly coated magnetic microparticles |
Detection limit |
0.12 mg/L. |
Calibrators |
included |
Incubations |
10 min |
Measuring range |
0.12-40 mg/L |
Sample type |
Serum/Plasma/Urine |
Sample size |
10 µL |
LIAISON® Calcitonin |
310940 |
Intended use |
For the quantitative determination of calcitonin in human serum |
Material provided |
Reagent Integral for 100 determinations |
Method |
Direct, two-site, sandwich type immunolumiometric assay using directly caoted magnetic microparticle |
Detection limit |
1 pg/mL |
Calibrators |
Included |
Incubations |
30 min |
Measuring range |
1.0-2000 pg/mL |
Sample type |
Serum |
Sample size |
150 µL |


